Standardized susceptibility testing of fluconazole: an international collaborative study
Michael A. Pfaller(University of Iowa), David W. Warnock(University of Alabama at Birmingham), Julian Müller(Oregon Health & Science University), B. Dupont(Délégation Paris 5), Thomas J. Walsh(Cornell University), Peter F. Troke, Michael G. Rinaldi(Murphy Oil Corporation (United States)), Smith Shadomy(University of Virginia), G S Kobayashi(Oregon Health & Science University), Ana Espinel-Ingroff(Oregon Health & Science University)
Cited by 73
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2015|4k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
|Clinical Infectious Diseases|2005|3k